印度口服霍乱疫苗配送策略:常规免疫还是运动式接种?范围综述
该范围综述基于Pubmed和Scopus文献,分析印度口服霍乱疫苗不同配送策略的效力、效果与成本。结果显示保护效力取决于覆盖率,反应性高风险接种优于环形和大众接种,疫苗充足时接种前运动更有效,学校接种(1-14岁)和5岁以下儿童接种具成本效果。缺乏常规免疫配送及1岁以下儿童的数据,需探索与现行扩大免疫规划兼容的策略。
要点
- OCV保护效力取决于覆盖率,反应性高风险接种优于环形和大众接种。
- 疫苗充足时接种前运动比反应性接种更有效;学校1-14岁接种在印度具成本效果。
- 缺乏常规免疫配送效果及1岁以下儿童安全性和效力数据。
核心结论
- 很少有证据表明大众运动式接种比常规扩大免疫规划(EPI)接种更经济有效。
- 需探索OCV配送策略是否与印度现行EPI兼容,可否在含麻疹疫苗年龄程序引入常规免疫,可选先在1-14岁热点地区开展运动式接种。
- 婴儿期OCV安全性和效力数据及热点监测是制定此类EPI政策的前提。
研究设计与样本
- 采用Arksey和O'Malley范围综述框架,检索Pubmed和Scopus中关于不同策略下口服霍乱疫苗配送的效力、效果和成本的文献。
主要发现
- OCV保护效力取决于其覆盖率。
- 反应性和接种前运动式接种的效果证据均可获得。
- 反应性高风险接种比反应性环形接种和大众接种更有效。
- 疫苗供应充足时,接种前运动比反应性接种更有效。
- 印度1-14岁年龄组通过学校开展接种前运动具成本效果;5岁以下儿童接种尽管效力低但因可避免更多病例而具成本效果。
关键数值与推荐
- 学校接种前运动在1-14岁年龄组具成本效果。
- 5岁以下儿童接种具成本效果,尽管效力低。
- 无证据关于OCV在1岁以下儿童中的效力和效果,以及通过常规免疫配送OCV的效果。
临床怎么用
- 可考虑在含麻疹疫苗年龄程序引入OCV常规免疫,可选先在1-14岁热点地区开展运动式接种。
- 制定EPI政策前需获取婴儿期OCV安全性和效力数据并开展热点监测。
局限性
- 缺乏常规免疫配送OCV效果及1岁以下儿童效力和效果证据。
- 少有证据比较大众运动式接种与常规EPI接种的经济性和有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Oral Cholera Vaccine (OCV) has been recognized as an adjunct tool for prevention and control of cholera. However, policy directions are currently unavailable in India to guide the vaccine delivery. We conducted a scoping review to inform the policy about the scopes and challenges of different strategic choices of OCV delivery in India in light of current evidences, highlighting the scope of new research. METHODS: Adopting the Arksey and O'Malley Framework for review, we searched for literatures on "efficacy", "effectiveness", and "cost" of oral cholera vaccine delivery through different strategies in Pubmed and Scopus. RESULTS: We found that the protective efficacy of OCV depends on its coverage. Evidence on effectiveness of OCV are available for both reactive and pre-vaccination campaigns. Reactive high-risk vaccination is more effective than reactive ring and mass vaccination. Pre-vaccination campaigns are more effective than reactive vaccination when vaccine availability is adequate. Pre-vaccination through school campaigns in 1-14 years age group have been cost effective in India. Vaccination campaigns in under-5 children are also cost effective in spite of low efficacy due to the scope of averting a higher number of cases. However, no evidence is available regarding efficacy and effectiveness of OCV in children <1 year as well as the effectiveness of delivering OCV through routine immunization. CONCLUSION: Little evidence exist to depict mass-campaign as more economic and effective than routine expanded programme on immunization (EPI) session for delivery of OCV. Considering operational feasibility, it needs to be explored whether OCV delivery strategy is compatible with India's current EPI, if it can be introduced in routine immunization at measles containing vaccine age-schedule, optionally preceded by a campaign in targeted hot-spots in the 1-14 year age-group. Safety and efficacy data of OCV during infancy as well as hot-spot surveillance are pre-requisites for formulation of such EPI policy.
引用
- Ray A, Sarkar K, Haldar P, et al. Oral cholera vaccine delivery strategy in India: Routine or campaign?-A scoping review. Vaccine. 2019. PMID: 31377080. doi:10.1016/j.vaccine.2019.07.082
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。